Difference between revisions of "Non-steroidal anti-inflammatory drug"
Jump to navigation
Jump to search
m (NSAID) |
(COX-2 is an enzyme, not an NSAID) |
||
| Line 1: | Line 1: | ||
'''Non-steroidal anti-inflammatory drugs''' ('''NSAID'''s) are [[drug]]s that relieve inflammation, fever, and often have [[analgesic]] properties. The prominent groups of non-steroidal anti-inflammatory drugs are salicylates, including [[aspirin]], Arylalkanoic acids, 2-Arylpropionic acids, including ibuprofen, N-Arylanthranilic acids, pyrazolidine derivatives, oxicams, and COX-2 Inhibitors. | '''Non-steroidal anti-inflammatory drugs''' ('''NSAID'''s) are [[drug]]s that relieve inflammation, fever, and often have [[analgesic]] properties. The prominent groups of non-steroidal anti-inflammatory drugs are salicylates, including [[aspirin]], Arylalkanoic acids, 2-Arylpropionic acids, including ibuprofen, N-Arylanthranilic acids, pyrazolidine derivatives, oxicams, and COX-2 Inhibitors. | ||
| − | The two primary [[adverse drug reactions]] of these drugs are irritation to the [[gastrointestinal tract]] and [[kidney]]s. In 1991 Daniel L. Simmons at [[Brigham Young University]] discovered COX-2 which | + | The two primary [[adverse drug reactions]] of these drugs are irritation to the [[gastrointestinal tract]] and [[kidney]]s. In 1991 Daniel L. Simmons at [[Brigham Young University]] discovered COX-2 inhibitors which were thought to be effective NSAIDs without gastrointestinal irritation, but little evidence of this exists. |
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 22:33, October 30, 2007
Non-steroidal anti-inflammatory drugs (NSAIDs) are drugs that relieve inflammation, fever, and often have analgesic properties. The prominent groups of non-steroidal anti-inflammatory drugs are salicylates, including aspirin, Arylalkanoic acids, 2-Arylpropionic acids, including ibuprofen, N-Arylanthranilic acids, pyrazolidine derivatives, oxicams, and COX-2 Inhibitors.
The two primary adverse drug reactions of these drugs are irritation to the gastrointestinal tract and kidneys. In 1991 Daniel L. Simmons at Brigham Young University discovered COX-2 inhibitors which were thought to be effective NSAIDs without gastrointestinal irritation, but little evidence of this exists.